Silicon Valley, July 23rd 2018

UCP Biosciences, Inc.—a leading supplier of In Vitro Diagnostics (IVD)—offers top notch Point of Care Testing (POCT) devices ranging from instant urine and saliva drug tests (in the U.S. Market) to Infectious Disease, Women’s Health, Cardiac Markers, and Tumor Markers (in the International Market).






In recent years, drug abuse in the US has spiked dramatically and stays at its highest rate in more than a decade. This results in an ever growing need for high quality and cost effective rapid drug screening devices. Therefore, we have a very rich product line based on colloidal gold nanoparticle technology in the US, China and around the world. Drug of Abuse are the mainstream products in the US with FDA, ISO13485, 510K, OTC and CLIA certifications, while international CE marked products include Infectious Disease (ID), Women’s Health (WH), Cardiac Markers (CM), and Tumor Markers (TM)—including automated devices such as u-CupTM reader and ultrafast quantitative biomarker scanner based on novel Fluorescence nanotechnology.